|
|
Article: Generex Biotechnology's Subsidiary Enters into Collaboration to Develop SARS Vaccine; Antigen Express to join with Leading Chinese Expert on SARS.
- Article from:
- PR Newswire
- Article date:
- February 23, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Generex Biotechnology Corporation announced today that it has entered into a collaboration with Dr. Bing Sun of the Chinese Academy of Science (IBC) in Shanghai to develop a SARS vaccine. Dr. Sun has done pioneering work isolating SARS genes which can be used in a DNA vaccine. Antigen Express, Generex's subsidiary, has developed proprietary and patented technologies to enhance the potency of DNA vaccines. Together they seek to create an effective DNA vaccine for protection against SARS infections.
Antigen Express' technology focuses on modulating immune responses mediated by T helper cells, a class of lymphocytes that plays many roles in the immune system, both ...